Guangzhou Innogen Pharmaceutical Group Co., Ltd. (2591)
Market Closed
12 Aug, 08:00
HKEX HKEX Primary 7. 10
HKD -0.1
-1.3889%
20.07B Market Cap
- P/E Ratio
- Div Yield
1.2M Volume
- Eps
7.2 HKD
Previous Close Want to track 2591 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Guangzhou Innogen Pharmaceutical Group Co., Ltd. (2591) Statistics
Valuation metrics
Market Cap 20.07B
Enterprise value 2.18B
Trailing P/E (ttm) -8.47
Forward P/E 78.89
PEG ratio -0.08
Price/Sales (ttm) 23.09
Price/Book (mrq) 2.74
Enterprise Value/Revenue 16.86
Enterprise Value/EBITDA -6.7
Overview
Shares outstanding 420.29M
Float 253.86M
Shares short -
% Held by insiders 0.58%
% Held by institutions 0.31%
Average volume (10 days) 2.35M
Average volume (90 days) 4.68M
Price summary
52-Week low 6.73
52-Week high 74
Beta -
50-Day moving average 7.73
200-Day moving average 16.7
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -2.6%
Operating margin -2.54%
Operational effectiveness
Return on assets -0.21%
Return on equity -0.38%
Income Statement
Revenue (ttm) 151.69M
Revenue per share (ttm) 0.29
Quarterly revenue growth (yoy) -
Gross profit (ttm) 135.02M
EBITDA -391.83M
Net income to common (ttm) -393.74M
Diluted EPS (ttm) -0.76
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 1.39B
Total cash per share (mrq) 2.73
Total debt (mrq) 191.76M
Total Debt/Equity (mrq) 0.16
Current ratio (mrq) 2.93%
Book value per share (mrq) 2.38
Cash Flow
Cash flow statement -340.88M
Levered free cash flow (LFCF) -258.53M
